Mechanisms underlying extremely fast muscle V˙O2 on-kinetics in humans

Physiological Reports
Bernard KorzeniewskiJerzy A Zoladz

Abstract

The time constant of the primary phase of pulmonary V˙O2 on-kinetics (τp ), which reflects muscle V˙O2 kinetics during moderate-intensity exercise, is about 30 s in young healthy untrained individuals, while it can be as low as 8 s in endurance-trained athletes. We aimed to determine the intramuscular factors that enable very low values of t0.63 to be achieved (analogous to τp , t0.63 is the time to reach 63% of the V˙O2 amplitude). A computer model of oxidative phosphorylation (OXPHOS) in skeletal muscle was used. Muscle t0.63 was near-linearly proportional to the difference in phosphocreatine (PCr) concentration between rest and work (ΔPCr). Of the two main factors that determine t0.63 , a huge increase in either OXPHOS activity (six- to eightfold) or each-step activation (ESA) of OXPHOS intensity (>3-fold) was needed to reduce muscle t0.63 from the reference value of 29 s (selected to represent young untrained subjects) to below 10 s (observed in athletes) when altered separately. On the other hand, the effect of a simultaneous increase of both OXPHOS activity and ESA intensity required only a twofold elevation of each to decrease t0.63 below 10 s. Of note, the dependence of t0.63 on OXPHOS activity and ESA intensity is hype...Continue Reading

References

Dec 1, 1991·Journal of Applied Physiology·T J Barstow, P A Molé
Oct 1, 1994·Journal of Applied Physiology·T J BarstowD M Cooper
Dec 1, 1995·Journal of Applied Physiology·S M PhillipsR L Hughson
Mar 1, 1996·Journal of Applied Physiology·B GrassiP D Wagner
May 23, 1998·The Biochemical Journal·B Korzeniewski
Aug 24, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·J BangsboB Saltin
Aug 31, 2001·Biophysical Chemistry·B Korzeniewski, J A Zoladz
Jan 28, 2004·The Biochemical Journal·Bernard Korzeniewski, Jerzy A Zoladz
Nov 13, 2004·American Journal of Physiology. Cell Physiology·Youngran ChungThomas Jue
Sep 24, 2005·Medicine and Science in Sports and Exercise·Bruno Grassi
Jun 20, 2006·The Journal of Physiological Sciences : JPS·Bernard Korzeniewski, Jerzy A Zoladz
Jun 15, 2007·Biophysical Chemistry·Bernard Korzeniewski
May 17, 2008·Journal of Applied Physiology·Jerzy A ZoladzBruno Grassi
Nov 17, 2009·Medicine and Science in Sports and Exercise·Bruno GrassiLucia Morandi
Mar 19, 2011·Journal of Applied Physiology·Scott R MurgatroydHarry B Rossiter
Jun 22, 2011·The Journal of Physiology·Rob C I WüstHarry B Rossiter
May 16, 2012·The Journal of Physiology·Steen LarsenMartin Hey-Mogensen
Dec 4, 2012·Experimental Physiology·Jerzy A ZoladzBernard Korzeniewski
Jun 15, 2013·Journal of Applied Physiology·Alan P BensonHarry B Rossiter
Oct 5, 2013·Medicine and Science in Sports and Exercise·Shunsaku KogaDavid C Poole
Nov 6, 2013·Exercise and Sport Sciences Reviews·Juan M MuriasDonald H Paterson
Aug 29, 2014·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Jerzy A ZoladzBernard Korzeniewski
Feb 18, 2015·Exercise and Sport Sciences Reviews·Bruno GrassiJerzy A Zoladz
Apr 2, 2015·Medicine and Science in Sports and Exercise·Russell S RichardsonPierre G Carlier
Aug 29, 2016·Pflügers Archiv : European journal of physiology·Jerzy A ZoladzWieslawa Jarmuszkiewicz
Dec 13, 2016·Progress in Biophysics and Molecular Biology·Bernard Korzeniewski

❮ Previous
Next ❯

Citations

Jan 25, 2020·The Journal of Physiology·David C PooleTimothy I Musch
Mar 18, 2021·European Journal of Applied Physiology·Erin Calaine InglisJuan M Murias

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.